Clickmer Systems

8. January 2018

There is increasing evidence that many antibodies that are currently on the market and used as detectors for proteins lack the required specificity. With its Clickmer approach, Clickmer Systems offers an alternative to antibodies for biological and clinical applications by employing detectors that are synthetic, more specific, highly reproducible, and cost effective.
Clickmer Systems has proof of concept data covered by International Patent applications WO 2015/049359 & WO 2016/050850.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.